Insulin Aspart (Niacinamide)

Brand name: Fiasp Flextouch

Rank #364 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$27.0M

Total Cost

Share:

24,598

Total Claims

$27.0M

Total Cost

1,185

Prescribers

$1,096

Cost per Claim

2,931

Beneficiaries

42,511

30-Day Fills

$23K

Avg Cost/Provider

21

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$27.0M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $27.0M total

🔎 Data Overview

💰

At $1,096 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $9,200 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Insulin Aspart (Niacinamide)

#ProviderSpecialtyLocationClaimsCost
1K. ThampyEndocrinologySaint Louis, MO326$603K
2Mohammed AnsariEndocrinologyShenandoah, TX181$155K
3K. ThampyEndocrinologySaint Louis, MO65$149K
4Brittany SimpsonNurse PractitionerSeymour, TN82$146K
5Kathryn PiburnNurse PractitionerBrandon, MS99$142K
6Susan MurryNurse PractitionerBryan, OH90$140K
7Abdallah AltarshanEndocrinologyEvergreen Park, IL125$125K
8Francis ArceInternal MedicineOswego, NY60$121K
9Richard Whetzel-SchillNurse PractitionerLake Mary, FL54$118K
10Hanna HendersonNurse PractitionerKnoxville, TN57$113K
11Richard Whetzel-SchillNurse PractitionerLake Mary, FL73$112K
12Jason DailyEndocrinologyFayetteville, AR94$104K
13Wayne WooEndocrinologyFlowood, MS129$98K
14Tooraj ZahediEndocrinologyForest Hills, NY93$96K
15Enzo RagucciEndocrinologyWest Nyack, NY62$94K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
361Trifluridine/Tipiracil Hcl (Lonsurf)$27.3M2,430
362Memantine Hcl/Donepezil Hcl (Namzaric)$27.2M46,134
363Solifenacin Succinate (Solifenacin Succinate)$27.1M343,174
364Insulin Aspart (Niacinamide) (Fiasp Flextouch)$27.0M24,598
365Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide)$26.8M2,304,445
366Dofetilide (Dofetilide)$26.7M98,814
367Plecanatide (Trulance)$26.6M36,026

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology